141080 — LigaChem Biosciences Share Price
0.000.00%
Last trade - 00:00- KR₩4tn
- KR₩3tn
- KR₩126bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 60.15 | ||
| PEG Ratio (f) | 1.03 | ||
| EPS Growth (f) | 140.92% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.28 | ||
| Price to Tang. Book | 6.37 | ||
| Price to Free Cashflow | 53.14 | ||
| Price to Sales | 30.72 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -3.37% | ||
| Return on Equity | 2.04% | ||
| Operating Margin | -16.64% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 49,393.7 | 32,157.01 | 33,412.04 | 34,145.64 | 125,898.14 | 282,323 | 230,268 | 16.97% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +729.37 | -19.35 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
LigaChem Biosciences Inc, formerly LegoChem Biosciences Inc, is a Korea-based company mainly engaged in development and discovery of new pharmaceuticals based on medical chemistry. The Company principally involves in the development of new drugs, including antibiotics, anticoagulants, anticancer, antiplatelet, anti-inflammatory, as well as antibody-drug-conjugates (ADC), among others. The Company provides technology transfer, joint and contact research and research services. In addition, the Company sells medical devices, medical supplies, prescription drugs, and over the counter (OTC) drugs.
Directors
- Yong Ju Kim PRE (58)
- Se Jin Park CFO (52)
- Dae Gyo Park EVP (54)
- Seong Ho Woo SVP (47)
- Rak Gyeong Song OTH (55)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 2nd, 2006
- Public Since
- May 10th, 2013
- No. of Shareholders
- 69,936
- No. of Employees
- 127
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 36,282,017
- Address
- 10, Gukjegwahak 10-ro, Yuseong-gu, DAEJEON, 34002
- Web
- https://www.legochembio.com/index.php
- Phone
- +82 428610688
- Auditors
- KPMG Samjong Accounting Corp
Upcoming Events for 141080
Q2 2025 LigaChem Biosciences Inc Earnings Release
Similar to 141080
3Billion
Korea Exchange - KOSDAQ
ABion
Korea Exchange - KOSDAQ
ABL Bio
Korea Exchange - KOSDAQ
Amicogen
Korea Exchange - KOSDAQ
AprilBio Co
Korea Exchange - KOSDAQ
FAQ
What is the LigaChem Biosciences share price?
As of Today at 21:45 UTC, shares in LigaChem Biosciences are trading at KR₩106,600. This share price information is delayed by 15 minutes.
How has the LigaChem Biosciences share price performed this year?
Shares in LigaChem Biosciences last closed at KR₩106,600 and the price had moved by +66.82% over the past 365 days. In terms of relative price strength the LigaChem Biosciences share price has outperformed the FTSE Developed Asia Pacific Index by +71.57% over the past year.
What are the analyst and broker recommendations for LigaChem Biosciences?
The overall consensus recommendation for LigaChem Biosciences is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the LigaChem Biosciences dividend yield?
LigaChem Biosciences does not currently pay a dividend.
Does LigaChem Biosciences pay a dividend?
LigaChem Biosciences does not currently pay a dividend.
When does LigaChem Biosciences next pay dividends?
LigaChem Biosciences does not currently pay a dividend.
How do I buy LigaChem Biosciences shares?
To buy shares in LigaChem Biosciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of LigaChem Biosciences?
As of the previous close price of KR₩106,600, shares in LigaChem Biosciences had a market capitalisation of KR₩4tn.
Where are LigaChem Biosciences shares listed?
Here are the trading details for LigaChem Biosciences:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 141080
What kind of share is LigaChem Biosciences?
Based on an overall assessment of its quality, value and momentum LigaChem Biosciences is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a LigaChem Biosciences share price forecast for 2025?
The analyst consensus target price for shares in LigaChem Biosciences is KR₩162,500. That is 52.44% above the last closing price of KR₩106,600.
Analysts covering LigaChem Biosciences currently have a consensus Earnings Per Share (EPS) forecast of KR₩1,884 for the next financial year.
Find out moreWhat is the trend in the LigaChem Biosciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LigaChem Biosciences. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -8.51%.
As of the last closing price of KR₩106,600, shares in LigaChem Biosciences were trading +2.78% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the LigaChem Biosciences PE Ratio?
The LigaChem Biosciences PE ratio based on its reported earnings over the past 12 months is 60.15. The shares last closed at KR₩106,600.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of LigaChem Biosciences?
LigaChem Biosciences' management team is headed by:
- Yong Ju Kim - PRE
- Se Jin Park - CFO
- Dae Gyo Park - EVP
- Seong Ho Woo - SVP
- Rak Gyeong Song - OTH